In an adult male with androgenetic (pattern) hair loss, which is more effective: finasteride (1 mg oral) or topical minoxidil (5 % solution or foam)?

Finasteride is Superior to Minoxidil for Male Androgenetic Alopecia

For adult men with androgenetic alopecia, oral finasteride 1 mg daily is more effective than topical minoxidil 5% and should be the first-line treatment when there are no contraindications. The evidence consistently demonstrates higher clinical cure rates and greater patient satisfaction with finasteride monotherapy compared to minoxidil alone.

Evidence Supporting Finasteride Superiority

The most direct comparative evidence shows finasteride achieving an 80% clinical cure rate (defined as increased hair intensity) versus only 52% for topical minoxidil 5% after 12 months of treatment 1. This represents a clinically meaningful 28% absolute difference in treatment success. Multiple systematic reviews and meta-analyses confirm both treatments are effective, but finasteride demonstrates consistently superior outcomes when directly compared 2, 3.

Practical Treatment Algorithm

Start with finasteride 1 mg daily if:

• Patient is male, age ≥18 years
• No plans for pregnancy with partner (finasteride contraindicated in pregnancy)
• No history of depression or sexual dysfunction concerns
• Hair loss primarily affects vertex/crown (where both drugs work best)

Switch to or add minoxidil 5% if:

• Sexual side effects develop on finasteride (occurs in ~15% based on 1)
• Patient refuses oral medication
• Frontal hairline involvement (finasteride less effective here per FDA labeling 4)
• After 4-6 months of finasteride with suboptimal response

Consider combination therapy from the start if:

• Extensive scalp involvement
• Rapid progression
• Patient desires maximum efficacy (combination shows additive benefits 5, 6, 7)

Key Mechanistic Differences

Finasteride works by blocking DHT conversion at the hormonal level—addressing the root cause of androgenetic alopecia. It reduces serum DHT by approximately 70%, directly preventing follicular miniaturization 1.

Minoxidil works through follicular stimulation—prolonging anagen phase and converting vellus hairs to terminal hairs 8. However, less than 5% of topically applied minoxidil is absorbed, and individual response depends heavily on sulfotransferase enzyme activity in the scalp, which varies unpredictably between patients 8.

Timeline Expectations

Both treatments require patience:

• Finasteride: Visible results typically at 3-6 months, maximum benefit at 12-24 months
• Minoxidil: Results may appear at 2 months but often require 4 months minimum 4
• Initial shedding: Expected with both treatments for up to 2 weeks (temporary, indicates treatment is working)

Critical Safety Considerations

Finasteride side effects (from 1):

• Loss of libido: ~15% of patients (6/40 in comparative trial)
• Erectile dysfunction: rare
• All side effects resolved upon discontinuation
• Serum testosterone increases slightly (compensatory)
• PSA decreases (important for prostate cancer screening—must inform urologist)

Minoxidil side effects:

• Scalp irritation: minimal (~4% in 1)
• Hypertrichosis (unwanted body hair): possible with oral formulation
• Cardiovascular effects: rare at low doses, but avoid in patients with heart disease
• Contact dermatitis: occasional with topical formulation

Common Pitfalls to Avoid

1. Stopping treatment prematurely: Both drugs require continuous use—hair loss resumes 3-4 months after discontinuation 4

2. Applying minoxidil incorrectly: Must apply directly to scalp (not just hair), allow 2-4 hours to dry before bed, avoid blow-drying immediately after application (reduces absorption by 50%) 8

3. Unrealistic expectations: Neither drug restores full hair density; finasteride primarily maintains existing hair and provides modest regrowth 4

4. Ignoring contraindications: Finasteride absolutely contraindicated if partner is pregnant or planning pregnancy (Category X)

When Neither Drug Alone is Sufficient

Recent evidence strongly supports combination therapy as superior to either monotherapy. Topical finasteride 0.1-0.25% combined with minoxidil 3-5% shows significantly better outcomes than minoxidil alone, with minimal systemic absorption and fewer sexual side effects than oral finasteride 5, 6, 7. This represents an excellent middle-ground option.

The newest data from 2025 shows combined oral minoxidil (2.5 mg) plus finasteride (1 mg) achieved 92.4% stable or improved outcomes with large effect sizes, particularly in severe cases 9. However, this remains off-label for minoxidil.

The bottom line: Start with finasteride 1 mg daily for maximum efficacy in treating the underlying pathophysiology of male pattern baldness, reserving minoxidil for patients who cannot tolerate or refuse finasteride, or adding it for enhanced results.